Pharmacological Treatments in Alcohol Use Disorder and Risk of Alcohol‐Related Hospitalizations: A Register Study
Results indicate a significant association between disulfiram and naltrexone monotherapy, as well as the combination of disulfiram with naltrexone or acamprosate, with a lower risk of alcohol-related hospitalizations among individuals with AUD. Low prescription rates suggest that AUD medications are currently underutilized. Increasing the availability of these medications for individuals with AUD could help reduce alcohol-related hospitalizations.
Authors
- Patrick Bach (ORCID: https://orcid.org/0000-0001-5962-019X)
- Mika Gissler (ORCID: https://orcid.org/0000-0001-8254-7525)
- Jeanette Westman (ORCID: https://orcid.org/0000-0001-8701-4226)
- Johan Franck (ORCID: https://orcid.org/0000-0002-4355-1967)
- Härje Widing (ORCID: https://orcid.org/0000-0002-4209-5728)
- Jonas Hällgren
Institutions
- Heidelberg University (DE)
- Turku University Hospital (FI)
- University Hospital Heidelberg (DE)
- Karolinska Institutet (SE)
- Finnish Institute for Health and Welfare (FI)
- Central Institute of Mental Health (DE)
- Stockholm Health Care Services (SE)
- Marie Cederschiöld University (SE)
Publication Details
- Journal
- Acta Psychiatrica Scandinavica
- Published
- 2025-03-17
- DOI
- https://doi.org/10.1111/acps.13802
- Citations
- 6
- Primary Topic
- Substance Abuse Treatment and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 8.13
Funders
- Forté Foundation
- Karolinska Institutet